MedPath

The study is to evaluate tramadol ,dexmedetomedine and clonidine as an adjuvant to levobupivacaine in supraclavicular brachial plexus block

Phase 4
Not yet recruiting
Conditions
Health Condition 1: - Health Condition 2: O- Medical and SurgicalHealth Condition 3: 8- Other Procedures
Registration Number
CTRI/2022/11/047386
Lead Sponsor
Jnu hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient who giving informed consent

Exclusion Criteria

Patients with previous history or clinical presentation with central or peripheral neurological disease, coagulopathy, infection at the site of injection, patient allergic to any of the study drugs and those unable to co-operate will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath